Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Signs of Accelerated Preclinical Atherosclerosis in Patients with Ankylosing Spondylitis

MIKE J.L. PETERS, IZHAR C. van EIJK, YVO M. SMULDERS, ERIK SERNE, BEN A.C. DIJKMANS, IRENE E. van der HORST-BRUINSMA and MICHAEL T. NURMOHAMED
The Journal of Rheumatology January 2010, 37 (1) 161-166; DOI: https://doi.org/10.3899/jrheum.090667
MIKE J.L. PETERS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IZHAR C. van EIJK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YVO M. SMULDERS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ERIK SERNE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BEN A.C. DIJKMANS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IRENE E. van der HORST-BRUINSMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHAEL T. NURMOHAMED
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mt.nurmohamed{at}vumc.nl
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Article Figures & Data

Figures

  • Tables
  • Carotid intima-media thickness: AS patients, 0.62 mm; controls, 0.57 mm (p = 0.02).
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Carotid intima-media thickness: AS patients, 0.62 mm; controls, 0.57 mm (p = 0.02).

Tables

  • Figures
    • View popup
    Table 1.

    Baseline characteristics of AS patients and controls.

    CharacteristicAS Patients, n = 59Controls, n = 30p
    Demographic
      Age, yrs39 (32–44)42 (29–57)0.13
      Men, %63630.75
    AS-related factors
      Disease duration, yrs9 (3–13)—
      BASDAI (range 0–10)6.2 (1.3)—
      BASFI (range 0–10)5.2 (1.9)—
      BASMI (range 0–10)3 (1–4)—
      HLA-B27, %88—
    Cardiovascular risk factors
      Smoking, %4714< 0.01
      Brachial systolic blood pressure, mm Hg119 (10)118 (11)0.55
      Brachial diastolic blood pressure, mm Hg69 (8)72 (8)0.07
      Brachial mean arterial pressure, mm Hg86 (7)86 (8)0.65
      Brachial pulse pressure, mm Hg51 (6)46 (7)0.01
      Heart rate, bpm65 (10)59 (10)0.02
      Total cholesterol, mmol/l5.0 (1.0)4.6 (0.8)0.42
      HDL cholesterol, mmol/l1.3 (0.3)1.4 (0.4)0.21
      Atherogenic index3.9 (1.1)3.4 (1.1)0.08
      Triglycerides, mmol/l1.1 (0.8–1.8)1.0 (0.8–1.4)0.62
      Body mass index, kg/m225 (5)24 (4)0.23
      Weight, kg76 (15)75 (14)0.55
      Height, cm176 (11)176 (9)0.65
      C-reactive protein, mg/l8 (3–25)0.8 (0.5–1.7)< 0.01
    Carotid artery properties
      Intima-media thickness, mm0.62 (0.09)0.57 (0.10)0.02
      Carotid diameter, mm6.95 (0.68)6.92 (0.73)0.86
      Carotid distension, μm561 (180)500 (162)0.14
      Carotid pulse pressure, mm Hg47 (7)44 (8)0.04
      Distensibility coefficient, 10−3 kPa−126.7 (20.5–31.9)26.2 (18.6–35.3)0.91
      Compliance coefficient, mm2* kPa−11.00 (0.80–1.20)0.95 (0.67–1.16)0.80
      Young’s elastic modulus, kPa0.42 (0.35–0.55)0.46 (0.35–0.60)0.39
    • Continuous variables are presented as means with standard deviations (SD) in case of normal distribution or as medians with interquartile ranges (IQR) in case of a non-normal distribution. Dichotomous variables are presented as number of cases and percentage of total.

    • View popup
    Table 2.

    Arterial wall properties in AS patients relative to controls.

    B95% CIp
    Intima-media thickness
      Crude0.0470.004 to 0.0900.021
      Multivariate (age, sex, and CV risk factors)0.0650.032 to 0.1250.001
    Carotid pulse pressure
      Crude4.0770.604 to 7.5500.040
      Multivariate3.5880.156 to 7.0200.041
    Distensibility coefficient
      Crude0.006−0.071 to 0.0840.868
      Multivariate−0.021−0.069 to 0.0270.388
    Compliance coefficient
      Crude0.014−0.059 to 0.0880.700
      Multivariate0.028−0.033 to 0.0900.362
    Young’s elastic modulus
      Crude−0.043−0.121 to 0.0340.271
      Multivariate−0.009−0.065 to 0.0480.755
    • Results are expressed as ß regression coefficient (95% CI). As the carotid stiffness indices (carotid distensibility, compliance, and elastic modulus) were not normally distributed, data are presented with the logarithms (natural) of these values. Variables included in the multivariate models were: age, sex, pulse pressure or mean arterial pressure, heart rate, smoking, atherogenic index, and C-reactive protein.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 37, Issue 1
1 Jan 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Signs of Accelerated Preclinical Atherosclerosis in Patients with Ankylosing Spondylitis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Signs of Accelerated Preclinical Atherosclerosis in Patients with Ankylosing Spondylitis
MIKE J.L. PETERS, IZHAR C. van EIJK, YVO M. SMULDERS, ERIK SERNE, BEN A.C. DIJKMANS, IRENE E. van der HORST-BRUINSMA, MICHAEL T. NURMOHAMED
The Journal of Rheumatology Jan 2010, 37 (1) 161-166; DOI: 10.3899/jrheum.090667

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Signs of Accelerated Preclinical Atherosclerosis in Patients with Ankylosing Spondylitis
MIKE J.L. PETERS, IZHAR C. van EIJK, YVO M. SMULDERS, ERIK SERNE, BEN A.C. DIJKMANS, IRENE E. van der HORST-BRUINSMA, MICHAEL T. NURMOHAMED
The Journal of Rheumatology Jan 2010, 37 (1) 161-166; DOI: 10.3899/jrheum.090667
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Effect of Bimekizumab Treatment on Health Status, Work Productivity, and Productivity Costs Through 3 Years in Axial Spondyloarthritis and Psoriatic Arthritis
  • Do People With Tophaceous Gout Require More Allopurinol for Good Clinical Outcomes? Analysis of 2 Randomized Controlled Trials of Allopurinol Dose Escalation
  • Overall and Sex-Specific Predictors of Secukinumab Effectiveness in European Patients With Psoriatic Arthritis: Results From the EuroSpA Collaboration
Show more Article

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire